How Do I Choose the Best Refractive Surgeon in My Area?
When considering refractive surgery to correct your vision, choosing the right surgeon is one of the most important decisions you’ll make. Whether you’re interested in LASIK eye surgery in Seattle or another type of vision correction procedure, your surgeon’s experience, skill, and reputation play a crucial role in achieving the best possible outcome. Here’s a…
Read More
How Much Should I Expect to Pay for Refractive Surgery?
Are you considering refractive surgery to correct your vision? Whether it’s SMILE, LASIK, PRK, or ICL, refractive surgery offers a life-changing solution for those looking to reduce or eliminate their dependence on glasses and contact lenses. But one of the most common questions patients ask is, “How much does refractive surgery cost?” Cost Range for…
Read More
Pediatric Blepharokeratoconjunctivitis
Provider Newsletter,Uncategorized
Pediatric Blepharokeratoconjunctivitis Pediatric blepharokeratoconjunctivitis (BKC) winds up in my chair way more than I would have predicted when I left optometry school. Our clinic sees this so much, we even have a drop-down phrase in our electronic record system for diagnosis and plan that we can adjust. This condition is a chronic inflammatory disease stemming…
Read More
Healthy Aging Eyes
Aging Eyes,Glaucoma,Provider Newsletter,Uncategorized
While no ocular fountain of youth exists and not all eye conditions are preventable, one of our most important roles as eye clinicians is helping the public maintain their vision and ocular health as they age. Unfortunately, there is still the idea among the public that if one has good vision, then they don’t need…
Read More
Pediatric Disc Edema Overview
Pediatric Disc Edema,Provider Newsletter,Uncategorized
Finding disc edema on one of your patients presents clinical challenges on its own, but this is exacerbated even further when you have a pediatric patient to manage. Although pediatric disc edema is less common than in adults, every provider should have a well-established plan of action to address any possible cases that are in…
Read More
Thyroid Eye Disease – No More NO SPECS
Provider Newsletter,Thyroid Eye Disease
Thyroid eye disease is an autoimmune condition affecting the ocular tissues. It occurs in up to 25% of patients with Graves’ disease. It is most common in patients who have hyperthyroidism (Graves’ disease), however, it can also occur under eurthyroid (10%) or autoimmune mediated hypothyroid conditions. Thyroid eye disease is more common in women,…
Read More
A Review of Corneal Edema in the Ocular Hypertensive Patient
Cornea,Glaucoma,Provider Newsletter,Uncategorized
The cornea is an avascular tissue, which relies on the atmosphere for the majority of its oxygen requirements and the aqueous humor for most of its other nutritional needs. The dehydrated state of the cornea is what allows for corneal transparency. When this dehydrated state is compromised, the result is corneal edema. The main factors…
Read More
Northwest Eye Clinical Research Update: The Glaukos iDose GC-012 Study
iDose GC-012 Study,Provider Newsletter,Uncategorized
Study Overview Northwest Eye Surgeons is happy to announce that Drs. Cameron and Kuzin are Principal Investigators in an active FDA approved Phase III clinical study on iDose Travoprost Intraocular Implants. This is a prospective, randomized masked three year study comparing novel implantable glaucoma medication delivery devices to topical timolol. One of two biocompatible…
Read More
Angle Closure
Glaucoma,Provider Newsletter,Uncategorized
According to the World Health Organization, glaucoma is the leading cause of preventable blindness worldwide. Glaucoma can be subdivided into two types based on anterior segment anatomy: open-angle glaucoma or angle-closure glaucoma. While open-angle glaucoma is the significantly more prevalent form of the two, angle-closure glaucoma is more likely to cause bilateral blindness. Angle closure…
Read More
Where to Start with Plaquenil Screenings
plaquenil screening,Provider Newsletter,Uncategorized
Plaquenil (hydroxychloroquine) has been thrusted into the spotlight due to the current COVID-19 pandemic. Its off-label use has been used a potential therapy for the virus, all data being anecdotal at best. Before COVID-19, Plaquenil was first used as an anti-malarial, but quickly started being used for a myriad of autoimmune diseases. The anti-inflammatory effects…
Read More
